Cibc World Markets Corp Has $8.31 Million Stock Holdings in Aflac Incorporated (NYSE:AFL)

Cibc World Markets Corp decreased its holdings in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 19.4% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 80,340 shares of the financial services provider's stock after selling 19,389 shares during the period. Cibc World Markets Corp's holdings in Aflac were worth $8,310,000 at the end of the most recent reporting period.

A number of other large investors also recently made changes to their positions in the stock. Whipplewood Advisors LLC bought a new stake in Aflac in the fourth quarter valued at about $26,000. Darwin Wealth Management LLC bought a new stake in shares of Aflac in the 3rd quarter valued at about $34,000. BankPlus Trust Department acquired a new stake in shares of Aflac in the 4th quarter valued at approximately $34,000. Raelipskie Partnership bought a new position in Aflac during the 3rd quarter worth approximately $38,000. Finally, OFI Invest Asset Management acquired a new position in Aflac during the fourth quarter valued at approximately $38,000. Institutional investors and hedge funds own 67.44% of the company's stock.

Aflac Stock Down 0.6 %

AFL stock traded down $0.61 during midday trading on Friday, hitting $108.10. The company's stock had a trading volume of 5,333,576 shares, compared to its average volume of 1,994,875. The company's fifty day moving average price is $105.95 and its 200 day moving average price is $107.64. The company has a debt-to-equity ratio of 0.29, a current ratio of 0.10 and a quick ratio of 0.08. Aflac Incorporated has a twelve month low of $79.31 and a twelve month high of $115.50. The stock has a market capitalization of $59.08 billion, a P/E ratio of 11.26, a PEG ratio of 3.24 and a beta of 0.93.

Remove Ads

Aflac (NYSE:AFL - Get Free Report) last released its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, equities research analysts predict that Aflac Incorporated will post 6.88 EPS for the current year.

Insider Transactions at Aflac

In other news, Director Charles D. Lake II sold 29,802 shares of the company's stock in a transaction dated Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the sale, the director now directly owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. This represents a 37.36 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total value of $107,630.00. Following the transaction, the director now owns 25,393 shares of the company's stock, valued at $2,733,048.59. The trade was a 3.79 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 55,546 shares of company stock worth $5,863,616 in the last 90 days. Corporate insiders own 0.80% of the company's stock.

Analyst Ratings Changes

Several research firms have weighed in on AFL. Wells Fargo & Company cut their target price on shares of Aflac from $104.00 to $102.00 and set an "equal weight" rating on the stock in a report on Wednesday, February 19th. StockNews.com upgraded Aflac from a "sell" rating to a "hold" rating in a report on Friday, February 14th. BMO Capital Markets initiated coverage on Aflac in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 target price for the company. Morgan Stanley raised their price target on Aflac from $98.00 to $105.00 and gave the stock an "equal weight" rating in a research report on Friday, February 28th. Finally, Evercore ISI cut their price objective on Aflac from $104.00 to $102.00 and set an "underperform" rating on the stock in a report on Wednesday, December 4th. Two analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company's stock. According to data from MarketBeat, Aflac currently has a consensus rating of "Hold" and a consensus target price of $103.36.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.